Nodality partners with pharmaceutical and biotechnology companies to aid in discovery, development, and commercialization of novel therapeutics. Nodality's proprietary technology, Single Cell Network Profiling (SCNP), has powerful applicability in various stages of the drug development process and in multiple disease indications, including cancer and autoimmune diseases. Nodality's proprietary SCNP technology provides critical advantages throughout the drug development process including:
Click to enlarge
If you are interested in collaborating with Nodality please contact us.